Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1

1(33.3%)

N/A

1(33.3%)

Phase 4

1(33.3%)

3Total

Phase 1(1)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07449689Phase 4Not Yet Recruiting

Comparing Acotiamide and Itopride for the Management of Indigestion

Role: collaborator

NCT06625346Recruiting

Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

Role: lead

NCT06437080Not ApplicableActive Not Recruiting

Hypoferritinemia Without Anemia Among Reproductive Age Females

Role: collaborator

NCT06628466Completed

Clinical Response of Nuberol Forte in Chronic Neck Pain in Routine Rehabilitation Centers

Role: lead

NCT05129761Completed

Clinical Response of Syrup Hydryllin® in Pakistani Subjects With Cough in Routine Practice

Role: lead

NCT04689919Phase 1Completed

Bioequivalence of Xaroban 20mg (Rivaroxaban) Tablet and Xarelto 20mg (Rivaroxaban) Tablet Under Fed Conditions

Role: collaborator

NCT04765787Completed

Safety & Efficacy of Nuberol Forte® in Pain Management

Role: lead

All 7 trials loaded